ARCHIVE

• CDFS Recommends 7 Ingredients Including Montelukast, Zolmitriptan for Approval
  May 28, 2001

• Protecting, Fostering Innovation Must Be Fundamental Part of Healthcare System: Dr McKinnell of PhRMA
  May 28, 2001

• BUSINESS NEWS IN BRIEF -3-
  May 28, 2001

• 5 of 7 Firms Including Takeda, Eisai, Daiichi Report Record-high Profits
  May 28, 2001

• Classification of Existing Drugs Proposed at Chuikyo
  May 28, 2001

• Mitsubishi-Tokyo: Sales Total \84.2 Bil.,Attributable to Growth of Mainstays
  May 28, 2001

• Industry Opposes Ministry Data on Prices of Original Products and Generics
  May 28, 2001

• Mitsubishi Chemical: Pharmaceutical Sales Top \127.4 Bil.
  May 28, 2001

• New Orphan Drugs, Medical Device Announced
  May 28, 2001

• WORLD NEWS IN BRIEF
  May 28, 2001

• Kyowa Hakko: Drug Sales Down to \141.4 Bil. Due to Suspension of Acenalin Shipment
  May 28, 2001

• Industry Must Accept Price Reduction for Long-listed Products: Health Minister
  May 28, 2001

• Anti-epileptic Zonisamide to Be Effective against Parkinson's Disease
  May 28, 2001

• Teijin: Pharmaceutical Sales Up 1.6% to \88.6 Bil.
  May 28, 2001

• None of the Current Proposals Stabilizes Health Insurance Finance: Kenporen Simulation
  May 28, 2001

• Seijo: Sales Up 15%, Operating Profits Down 3%
  May 28, 2001

• Kobayashi Pharmaceutical: Record-high Sales, Profits
  May 28, 2001

• REGULATORY NEWS IN BRIEF
  May 28, 2001

• PAJ's Council on Self-medication Promotion to Start Discussions in June
  May 28, 2001

• Long-Term Incentives Are Essential to Develop New Drugs: Dr McKinnell
  May 28, 2001

ページ

• « 先頭
• ‹ Prev
• …
• 754
• 755
• 756
• 757
• 758
• 759
• 760
• 761
• 762
• …
• Next ›
• 最終 »